000239250 000__ 01587cam\a2200361\a\45e0
000239250 001__ 239250
000239250 005__ 20220217104430.0
000239250 008__ 980506s1997\\\\dcu\\\\\\\\\\f000\0\eng\c
000239250 010__ $$a   98147308
000239250 020__ $$a0160558271 :$$c$11.00
000239250 035__ $$a(OCoLC)ocm38226236
000239250 035__ $$a239250
000239250 040__ $$aDGPO/DLC$$cGPO$$dDLC$$dISE
000239250 043__ $$an-us---
000239250 049__ $$aISEA
000239250 05000 $$aKF27$$b.G663 1997m
000239250 074__ $$a1016-A
000239250 074__ $$a1016-B (MF)
000239250 0860_ $$aY 4.G 74/7:OV 2/15
000239250 088__ $$aSerial no. 105-49 (United States. Congress. House. Committee on Government Reform and Oversight)
000239250 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Government Reform and Oversight.$$bSubcommittee on Human Resources.
000239250 24510 $$aOversight of NIH and FDA :$$bbioethics and the adequacy of informed consent : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, May 8, 1997.
000239250 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1997.
000239250 300__ $$aiii, 228 p. ;$$c23 cm.
000239250 500__ $$aDistributed to some depository libraries in microfiche.
000239250 500__ $$aShipping list no.: 98-0089-P.
000239250 500__ $$a"Serial no. 105-49."
000239250 61020 $$aNational Institutes of Health (U.S.)
000239250 61010 $$aUnited States.$$bFood and Drug Administration.
000239250 650_0 $$aBioethics$$zUnited States.
000239250 650_0 $$aMedical ethics$$zUnited States.
000239250 650_0 $$aInformed consent (Medical law)$$zUnited States.
000239250 85230 $$bdfich$$hY 4.G 74/7:$$iOV 2/15
000239250 909CO $$ooai:library.usi.edu:239250$$pGLOBAL_SET
000239250 980__ $$aBIB
000239250 980__ $$aGOV RESOURCE
000239250 994__ $$aE0$$bISE